StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research note published on Sunday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Performance
Shares of CPIX opened at $1.28 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.44 and a quick ratio of 1.26. Cumberland Pharmaceuticals has a one year low of $1.25 and a one year high of $2.36. The company’s fifty day moving average price is $1.40 and its 200 day moving average price is $1.55. The company has a market capitalization of $18.16 million, a PE ratio of -2.17 and a beta of 0.20.
Cumberland Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Cumberland Pharmaceuticals
- What is the Dow Jones Industrial Average (DJIA)?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- There Are Different Types of Stock To Invest In
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.